What Arrowhead Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 2 | 64 |
| Total trades | 2 | 88 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 523,341 |
| Disposed | 13,600 | 565,801 |
| Net activity | −13,600 | −42,460 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Olukotun Adeoye Y | Director | Aug 18 | Open-market sale · S | −2,000 | $86.96 | −$174K | 31,600 |
| Perry Michael S | Director | Aug 18 | Open-market sale · S | −11,600 | $87.30 | −$1.01M | 111,459 |
| Cohen Matthew Gregory | Director | Jun 15 | Grant / award · A | +11,882 | — | — | 11,882 |
| Lu Hongbo | Director | May 12 | Open-market sale · S | −2,970 | $76.88 | −$228K | 52,012 |
| Hamilton James C | Chief Medical Officer | Apr 23 | Open-market sale · S | −10,000 | $75.00 | −$750K | 226,958 |
| Apel Daniel Joseph | Chief Financial Officer | Apr 22 | Sale for tax withholding · S | −8,730 | $71.92 | −$628K | 162,905 |
| Apel Daniel Joseph | Chief Financial Officer | Apr 22 | Sale for tax withholding · S | −1,157 | $70.45 | −$81.5K | 171,635 |
| Apel Daniel Joseph | Chief Financial Officer | Apr 22 | Sale for tax withholding · S | −3,208 | $70.11 | −$225K | 172,792 |
| Hamilton James C | Chief Medical Officer | Mar 05 | Open-market sale · S | −10,000 | $64.19 | −$642K | 236,958 |
| O'Brien Patrick | COO | Jan 06 | Grant / award · A | +75,000 | — | — | 547,408 |
| O'Brien Patrick | COO | Jan 06 | Gift · G | −440 | — | — | 472,408 |
| O'Brien Patrick | COO | Jan 06 | Gift · G | −440 | — | — | 472,848 |
| O'Brien Patrick | COO | Jan 06 | Gift · G | −540 | — | — | 473,288 |
| O'Brien Patrick | COO | Jan 06 | Gift · G | −540 | — | — | 473,828 |
| O'Brien Patrick | COO | Jan 06 | Gift · G | −540 | — | — | 474,368 |
| Hamilton James C | Chief Medical Officer | Jan 06 | Grant / award · A | +75,000 | — | — | 246,958 |
| Apel Daniel Joseph | Chief Financial Officer | Jan 06 | Grant / award · A | +75,000 | — | — | 176,200 |
| O'Brien Patrick | COO | Jan 05 | Open-market sale · S | −46 | $68.00 | −$3.13K | 474,908 |
| O'Brien Patrick | COO | Jan 05 | Open-market sale · S | −2,336 | $64.04 | −$150K | 474,954 |
| O'Brien Patrick | COO | Jan 05 | Open-market sale · S | −5,873 | $62.91 | −$369K | 477,290 |
Loading...
